On January 15, 2025, the federal Drug Enforcement Administration (DEA) issued a notice of proposed rulemaking (NPRM) regarding prescribing ...

On January 15, 2025, the US Drug Enforcement Administration (DEA) released a proposed rule entitled Special Registrations for ...

Opens in a new tab or window Physicians would have to register with the Drug Enforcement Administration (DEA ... III-V controlled substances would need to apply for a special registration ...

The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration ... II-V controlled substances with the DEA.

Now, the DEA has released a potential ... to prescribe Schedule II to V controlled substances. Providers would also have to maintain a state telemedicine registration for each state they practice ...

Healthcare providers will finally get a special registration to dispense controlled ... verification, electronic recordkeeping, and ongoing monitoring.” “We are pleased to see the DEA propose ...

On Wednesday, the DEA released a proposed rule that would set up a special registration process for remote prescribing of Schedule II-V controlled substances such as Xanax, Vicodin and Adderall.

Long-term care providers who prescribe controlled substances via telehealth ... break operators into three levels that the DEA calls Special Registration tiers: The Telemedicine Prescribing ...

Physicians would have to register with the Drug Enforcement Administration (DEA ... prescribe Schedule III-V controlled substances would need to apply for a special registration; substances ...

The proposed rule for remote prescribing of controlled substances sets up a special registration process for providers based on three tiers. For all eligible providers, the DEA is proposing to ...